Skip to content

Commit

Permalink
Merge pull request #6 from openpharma/pre-release/v0.1.0
Browse files Browse the repository at this point in the history
v0.1.0 released version
  • Loading branch information
dgkf authored Feb 19, 2024
2 parents 617d613 + 5ecfbd9 commit a46e491
Show file tree
Hide file tree
Showing 3 changed files with 14 additions and 9 deletions.
17 changes: 10 additions & 7 deletions DESCRIPTION
Original file line number Diff line number Diff line change
@@ -1,6 +1,6 @@
Package: roxylint
Title: Lint 'roxygen2'-generated documentation
Version: 0.0.0.9001
Title: Lint 'roxygen2'-Generated Documentation
Version: 0.1.0
Authors@R:
c(
person(
Expand All @@ -9,19 +9,22 @@ Authors@R:
role = c("aut", "cre")
)
)
Description: Provides formatting linting to roxygen2 tags.
Description: Provides formatting linting to 'roxygen2' tags. Linters report
'roxygen2' tags that do not conform to a standard style. These linters
can be a helpful check for building more consistent documentation and
to provide reminders about best practices or checks for typos. Default
linting suites are provided for common style guides such as the one
followed by the 'tidyverse', though custom linters can be registered by
other packages or be custom-tailored to a specific package.
License: MIT + file LICENSE
Encoding: UTF-8
URL:
https://github.com/openpharma/roxylint,
https://openpharma.github.io/roxylint
https://openpharma.github.io/roxylint/
BugReports:
https://github.com/openpharma/roxylint/issues
Imports:
utils,
cli,
roxygen2
Config/Needs/documentation:
roxylint,
roxytypes
RoxygenNote: 7.2.3
3 changes: 3 additions & 0 deletions NEWS.md
Original file line number Diff line number Diff line change
@@ -0,0 +1,3 @@
# roxylint v0.1.0

* first CRAN release
3 changes: 1 addition & 2 deletions man/roxygen/meta.R
Original file line number Diff line number Diff line change
@@ -1,8 +1,7 @@
list(
markdown = TRUE,
packages = c(
"roxylint",
"roxytypes"
"roxylint"
),
roclets = c(
"namespace",
Expand Down

0 comments on commit a46e491

Please sign in to comment.